Digitisation | May 12, 2026
HealthQuad invests in AI-powered LifeSigns
Investment will support LifeSigns’ global expansion across Southeast Asia and GCC markets
Investment will support LifeSigns’ global expansion across Southeast Asia and GCC markets
Healthcare operations veteran with over 23 years of experience to lead key initiatives across South India
U.S. business drives strong growth as Lupin reports 57% rise in Q4 U.S. sales and 43% increase in gross profit
LIR Life is working on a patch-based, transdermal delivery system for GLP-1 therapies targeting obesity
The standout story remains Wegovy, particularly its new oral formulation
The investment will upgrade and expand production capabilities at Lilly Lebanon API and Lilly Lebanon Advanced Therapies
The proposed biosimilar to Keytruda demonstrated pharmacokinetic bioequivalence in a multicountry Phase 1 study involving non-small cell lung cancer patients
The pharmaceutical giant reported $14.5 billion in revenue, up 5% year-over-year, and reaffirmed its full-year outlook
Pharma and healthcare stocks stay in focus as investors track earnings, USFDA approvals, hospital growth, and global market pressures
Growth was supported by stronger COVID vaccine sales and expanded government supply agreements in international markets
Subscribe To Our Newsletter & Stay Updated
